← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 3, 2020Last known activity
Mar 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (14)
- NCT06410352CollaboratorPhase 4Mar 1, 2023
- NCT05484505CollaboratorEarly Phase 1Nov 1, 2022
- NCT05693428Reponsible party - principal investigatorN/AJan 22, 2022
- NCT05693428Study chairN/AJan 22, 2022
- NCT05693428Lead sponsorN/AJan 22, 2022
- NCT05742789Reponsible party - principal investigatorPhase 1Nov 30, 2021
- NCT05742789Lead sponsorPhase 1Nov 30, 2021
- NCT05742789Study directorPhase 1Nov 30, 2021
- NCT05695287Reponsible party - principal investigatorPhase 1Jan 22, 2021
- NCT05695287Study directorPhase 1Jan 22, 2021
- NCT05695287Lead sponsorPhase 1Jan 22, 2021
- NCT05696509Reponsible party - principal investigatorPhase 3Jan 3, 2020
- NCT05696509Lead sponsorPhase 3Jan 3, 2020
- NCT05696509Study chairPhase 3Jan 3, 2020
Details
- Last known activity
- Mar 1, 2023